메뉴 건너뛰기




Volumn 29, Issue 5, 2009, Pages 392-397

Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: Role of anti-inflammation effects

Author keywords

Dialysis; Erythropoietin stimulating agent; Inflammation; Statins

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; ERYTHROPOIETIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 18; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

EID: 54949085025     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000169658     Document Type: Article
Times cited : (25)

References (31)
  • 1
    • 0031970298 scopus 로고    scopus 로고
    • High-dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients
    • Albitar S, Genin R, Fen-Chong M, Serveaux MO, Bourgeon B: High-dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients. Nephrol Dial Transplant 1998; 13:1206-1210.
    • (1998) Nephrol Dial Transplant , vol.13 , pp. 1206-1210
    • Albitar, S.1    Genin, R.2    Fen-Chong, M.3    Serveaux, M.O.4    Bourgeon, B.5
  • 2
    • 18744431818 scopus 로고    scopus 로고
    • The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in haemodialysis patients
    • Erturk S, Nergizoglu G, Ates K, Duman N, Erbay B, Karatan O, Ertug AE: The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in haemodialysis patients. Nephrol Dial Transplant 1999; 14:1912-1916.
    • (1999) Nephrol Dial Transplant , vol.14 , pp. 1912-1916
    • Erturk, S.1    Nergizoglu, G.2    Ates, K.3    Duman, N.4    Erbay, B.5    Karatan, O.6    Ertug, A.E.7
  • 3
    • 0030021933 scopus 로고    scopus 로고
    • The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease
    • Ifudu O, Feldman J, Friedman EA: The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 1996;334:420-425.
    • (1996) N Engl J Med , vol.334 , pp. 420-425
    • Ifudu, O.1    Feldman, J.2    Friedman, E.A.3
  • 4
    • 0027533230 scopus 로고
    • Effect of serum parathyroid hormone and bone marrow fi-brosis on the response to erythropoietin in uremia
    • Rao DS, Shih MS, Mohini R: Effect of serum parathyroid hormone and bone marrow fi-brosis on the response to erythropoietin in uremia. N Engl J Med 1993;328:171-175.
    • (1993) N Engl J Med , vol.328 , pp. 171-175
    • Rao, D.S.1    Shih, M.S.2    Mohini, R.3
  • 5
    • 28844432970 scopus 로고    scopus 로고
    • Quality of life in Turkish haemodialysis patients
    • Acaray A, Pinar R: Quality of life in Turkish haemodialysis patients. Int Urol Nephrol 2005;37:595-602.
    • (2005) Int Urol Nephrol , vol.37 , pp. 595-602
    • Acaray, A.1    Pinar, R.2
  • 7
    • 0142157722 scopus 로고    scopus 로고
    • Long-term study of high-co-morbidity ESRD patients converted from conventional to short daily hemodialysis
    • Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S: Long-term study of high-co-morbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003;42:1020-1035.
    • (2003) Am J Kidney Dis , vol.42 , pp. 1020-1035
    • Ting, G.O.1    Kjellstrand, C.2    Freitas, T.3    Carrie, B.J.4    Zarghamee, S.5
  • 10
    • 29244475380 scopus 로고    scopus 로고
    • Serum albumin, C-reactive protein, interleukin-6, and fetuin as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD
    • Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin-6, and fetuin as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006;47:139-148.
    • (2006) Am J Kidney Dis , vol.47 , pp. 139-148
    • Honda, H.1    Qureshi, A.R.2    Heimburger, O.3    Barany, P.4    Wang, K.5    Pecoits-Filho, R.6    Stenvinkel, P.7    Lindholm, B.8
  • 13
    • 0036055582 scopus 로고    scopus 로고
    • C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients
    • Wanner C, Metzger T: C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant 2002;17(suppl 8):29-32.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.SUPPL. 8 , pp. 29-32
    • Wanner, C.1    Metzger, T.2
  • 14
    • 33845268461 scopus 로고    scopus 로고
    • Dissecting inflammation in ESRD: Do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients?
    • Zoccali C, Tripepi G, Mallamaci F: Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? J Am Soc Nephrol 2006; 17: S169-S173.
    • (2006) J Am Soc Nephrol , vol.17
    • Zoccali, C.1    Tripepi, G.2    Mallamaci, F.3
  • 15
    • 0035159542 scopus 로고    scopus 로고
    • The role of inflammation in the anaemia of end-stage renal disease
    • Stenvinkel P: The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 2001; 16(suppl 7):36-40.
    • (2001) Nephrol Dial Transplant , vol.16 , Issue.SUPPL. 7 , pp. 36-40
    • Stenvinkel, P.1
  • 16
    • 0042809701 scopus 로고    scopus 로고
    • Decreased erythropoietin requirements in maintenance hemodialysis patients with statin therapy
    • Sirken G, Kung SC, Raja R: Decreased erythropoietin requirements in maintenance hemodialysis patients with statin therapy. ASAIO J 2003;49:422-425.
    • (2003) ASAIO J , vol.49 , pp. 422-425
    • Sirken, G.1    Kung, S.C.2    Raja, R.3
  • 17
    • 33646054515 scopus 로고    scopus 로고
    • Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients?
    • Chen LP, Chiang CK, Chan CP, Hung KY, Huang CS: Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients? Am J Kidney Dis 2006; 47:815-822.
    • (2006) Am J Kidney Dis , vol.47 , pp. 815-822
    • Chen, L.P.1    Chiang, C.K.2    Chan, C.P.3    Hung, K.Y.4    Huang, C.S.5
  • 19
    • 32944476078 scopus 로고    scopus 로고
    • Plasma interleukin-18 levels in hemodialysis patients: Increased by dialysis process and association with interleukin-6 and tumor necrotic factor-a
    • Chiang CK, Huang JW, Hsu SP, Ho TI, Pai MF, Peng YS, Liu SH, Hung KY, Tsai TJ: Plasma interleukin-18 levels in hemodialysis patients: increased by dialysis process and association with interleukin-6 and tumor necrotic factor-a. Blood Purif 2006;24:174-179.
    • (2006) Blood Purif , vol.24 , pp. 174-179
    • Chiang, C.K.1    Huang, J.W.2    Hsu, S.P.3    Ho, T.I.4    Pai, M.F.5    Peng, Y.S.6    Liu, S.H.7    Hung, K.Y.8    Tsai, T.J.9
  • 20
    • 4344691085 scopus 로고    scopus 로고
    • Effects of atorvastatin on triglyceride-rich li-poproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients
    • Ikejiri A, Hirano T, Murayama S, Yoshino G, Gushiken N, Hyodo T, Taira T, Adachi M: Effects of atorvastatin on triglyceride-rich li-poproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients. Metabolism 2004;53:1113-1117.
    • (2004) Metabolism , vol.53 , pp. 1113-1117
    • Ikejiri, A.1    Hirano, T.2    Murayama, S.3    Yoshino, G.4    Gushiken, N.5    Hyodo, T.6    Taira, T.7    Adachi, M.8
  • 21
    • 0035125858 scopus 로고    scopus 로고
    • Role of uremic toxins in exacerbating anemia in renal failure
    • Macdougall IC: Role of uremic toxins in exacerbating anemia in renal failure. Kidney Int 2001;78:S67-S72.
    • (2001) Kidney Int , vol.78
    • Macdougall, I.C.1
  • 22
    • 0026760450 scopus 로고
    • Progress in understanding the pathogenesis of the anemia of chronic disease
    • Means RT Jr, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80:1639-1647.
    • (1992) Blood , vol.80 , pp. 1639-1647
    • Means Jr, R.T.1    Krantz, S.B.2
  • 23
    • 0023223250 scopus 로고
    • Inhibition by interleukin-1 of the action of eryth-ropoietin on erythroid precursors and its possible role in the pathogenesis of hypo-plastic anaemias
    • Schooley JC, Kullgren B, Allison AC: Inhibition by interleukin-1 of the action of eryth-ropoietin on erythroid precursors and its possible role in the pathogenesis of hypo-plastic anaemias. Br J Haematol 1987;67:11-17.
    • (1987) Br J Haematol , vol.67 , pp. 11-17
    • Schooley, J.C.1    Kullgren, B.2    Allison, A.C.3
  • 24
    • 0026569973 scopus 로고
    • Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys
    • Jelkmann W, Pagel H, Wolff M, Fandrey J: Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1992; 50:301-308.
    • (1992) Life Sci , vol.50 , pp. 301-308
    • Jelkmann, W.1    Pagel, H.2    Wolff, M.3    Fandrey, J.4
  • 25
    • 0023192336 scopus 로고
    • Acute in vivo effects of human recombi-nant tumor necrosis factor
    • Remick DG, Kunkel RG, Larrick JW, Kunkel SL: Acute in vivo effects of human recombi-nant tumor necrosis factor. Lab Invest 1987; 56:583-590.
    • (1987) Lab Invest , vol.56 , pp. 583-590
    • Remick, D.G.1    Kunkel, R.G.2    Larrick, J.W.3    Kunkel, S.L.4
  • 26
    • 0023501870 scopus 로고
    • Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-α in rodents
    • Patton JS, Peters PM, McCabe J, Crase D, Hansen S, Chen AB, Liggitt D: Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-α in rodents. J Clin Invest 1987; 80:1587-1596.
    • (1987) J Clin Invest , vol.80 , pp. 1587-1596
    • Patton, J.S.1    Peters, P.M.2    McCabe, J.3    Crase, D.4    Hansen, S.5    Chen, A.B.6    Liggitt, D.7
  • 28
    • 16344366601 scopus 로고    scopus 로고
    • Low-density lipoprotein cholesterol: Association with mortality and hospitalization in hemodialysis patients
    • Chiang CK, Ho TI, Hsu SP, Peng YS, Pai MF, Yang SY, Hung KY, Tsai TJ: Low-density lipoprotein cholesterol: association with mortality and hospitalization in hemodialysis patients. Blood Purif 2005;23:134-140.
    • (2005) Blood Purif , vol.23 , pp. 134-140
    • Chiang, C.K.1    Ho, T.I.2    Hsu, S.P.3    Peng, Y.S.4    Pai, M.F.5    Yang, S.Y.6    Hung, K.Y.7    Tsai, T.J.8
  • 29
    • 0036233727 scopus 로고    scopus 로고
    • Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients
    • Iseki K, Yamazato M, Tozawa M, Takishita S: Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 2002;61:1887-1893.
    • (2002) Kidney Int , vol.61 , pp. 1887-1893
    • Iseki, K.1    Yamazato, M.2    Tozawa, M.3    Takishita, S.4
  • 30
    • 0037337398 scopus 로고    scopus 로고
    • Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
    • Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808.
    • (2003) Kidney Int , vol.63 , pp. 793-808
    • Kalantar-Zadeh, K.1    Block, G.2    Humphreys, M.H.3    Kopple, J.D.4
  • 31
    • 41449093519 scopus 로고    scopus 로고
    • Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-re-gression of randomised controlled trials
    • Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC: Effects of statins in patients with chronic kidney disease: meta-analysis and meta-re-gression of randomised controlled trials. BMJ 2008;336:645-651.
    • (2008) BMJ , vol.336 , pp. 645-651
    • Strippoli, G.F.1    Navaneethan, S.D.2    Johnson, D.W.3    Perkovic, V.4    Pellegrini, F.5    Nicolucci, A.6    Craig, J.C.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.